Skip to content

Safety and Effectiveness of Cortical Stimulation in the Treatment of Stroke Patients With Upper Extremity Hemiparesis

Safety and Effectiveness of Targeted Sub-Threshold Epidural Cortical Stimulation Delivered Concurrent With Rehabilitation Activities to Enhance Motor Recovery in Patients Suffering From Upper Extremity Hemiparesis Following a Stroke

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00170716
Acronym
EVEREST
Enrollment
174
Registered
2005-09-15
Start date
2004-09-30
Completion date
2008-03-31
Last updated
2007-12-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemiparesis, Stroke

Keywords

Motor Cortex Electrical Stimulation, Ischemic Stroke, Upper Extremity Hemiparesis, Rehabilitation, Motor Recovery, Functional MRI

Brief summary

The purpose of this study is to assess the safety and effectiveness of cortical stimulation delivered concurrent with rehabilitation activities to enhance motor recovery in patients suffering from hemiparesis affecting the upper extremity following a stroke.

Detailed description

Stroke is a leading cause of serious, long-term disability in the United States. According to the American Stroke Association, the prevalence of stroke in the U.S. is approximately 4.8 million with approximately 700,000 additional strokes occurring annually. The 2001 overall death rate for stroke was 58%. Of those who survive, 30 to 50 percent do not regain functional independence, 15 to 30 percent are permanently disabled, and 20% require institutional care at three months after onset. The most common neurological deficit among these stroke survivors, and thus a substantial contributor to post-stroke disability, is a motor weakness on one (hemiparesis) side of the body. Presently, the only treatment available for patients with motor deficits is rehabilitative therapy. However, many patients are not responsive to standard rehabilitative therapy or achieve a less than satisfactory improvement in function. The primary objective of this study is to determine the safety and effectiveness of targeted sub-threshold epidural cortical stimulation delivered concurrent with rehabilitation activities to enhance motor recovery in patients suffering from hemiparesis (a motor weakness in one half of the body) affecting the upper extremity (shoulder, arm, wrist, hand) following a stroke. In addition to evaluating changes from baseline level, safety and efficacy measures will be compared to patients who undergo the same rehabilitation activities but without cortical stimulation. The two study groups will be compared to determine the degree to which motor function of the affected limb can be improved beyond rehabilitation alone by epidural stimulation of a targeted cortical region.

Interventions

DEVICECortical Stimulation and rehabilitation

Cortical stimulation is provided concomitantly with rehabilitation therapy. Rehabilitation is for 2.5 hrs per day for 26 days over a period of 6 weeks.

OTHERRehabilitation

Rehabilitation is for 2.5 hrs per day for 26 days over a period of 6 weeks.

Sponsors

Northstar Neuroscience
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects must have an ischemic stroke. * Moderate to moderately severe upper-extremity hemiparesis. * Aged 21 years or older.

Exclusion criteria

* Primary hemorrhagic stroke. * Any additional stroke associated with incomplete motor recovery. * Any neurologic or physical condition impairing function of the target extremity. * History of seizure disorder. * History of spinal cord injury, traumatic brain injury, or spontaneous subdural or epidural hematoma that has resulted in a neurologic deficit. * Contraindication to magnetic resonance (MR) imaging.

Design outcomes

Primary

MeasureTime frame
Arm Motor Ability Test (AMAT) scoreFollow Up Week 4
Arm Motor Fugl-Meyer (AMFM) scoreFollow Up Week 4

Secondary

MeasureTime frame
Box and Block Test scoreFollow Up Week 4
Stroke Specific Quality of Life (SSQOL) scoreFollow Up Week 4
Serious adverse event rateFollow up week 4 and 6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026